Fred B. Davenport Jr.
President, PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC.
Companies
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 19, 2026Sold 7,283 shares at $606.15 of Medpace2
- Aug 19, 2026Exercised options 1,822 shares at $164.68 of Medpace2
- Aug 19, 2026Exercised options 3,858 shares at $84.36 of Medpace2
- Aug 19, 2026Exercised options 1,903 shares at $133.87 of Medpace2
- Oct 30, 2025Sold 5,972 shares at $581.88 of Medpace3
- Oct 30, 2025Exercised options 6,472 shares at $54.99 of Medpace3
- Apr 24, 2025Sold 1,712 shares at $301.82 of Medpace4
- Apr 24, 2025Exercised options 4,710 shares at $57.17 of Medpace4
- Feb 17, 2022Bought 500 shares at $145.80 of Medpace5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARMedpace, Board member
- 2
- 3SEC EDGARForm 4 filed Nov 3, 2025
- 4SEC EDGARForm 4 filed Apr 28, 2025
- 5SEC EDGARForm 4 filed Feb 22, 2022